Literature DB >> 4559064

A model in vitro system to test the susceptibility of human malarial parasites to antimalarial drugs.

W A Siddiqui, J V Schnell, Q M Geiman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4559064

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  7 in total

1.  Roles of conserved and allelic regions of the major merozoite surface protein (gp195) in immunity against Plasmodium falciparum.

Authors:  G S Hui; A Hashimoto; S P Chang
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

2.  Serotypes of Plasmodium falciparum defined by immune serum inhibition of in vitro growth.

Authors:  J D Chulay; J D Haynes; C L Diggs
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

3.  Concentration and separation of erythrocytes infected with Plasmodium falciparum by gradient centrifugation.

Authors:  J E Mrema; G H Campbell; R Miranda; A L Jaramillo; K H Rieckmann
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

4.  Activities of various 4-aminoquinolines against infections with chloroquine-resistant strains of Plasmodium falciparum.

Authors:  L H Schmidt; D Vaughan; D Mueller; R Crosby; R Hamilton
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

5.  5HT1A serotonin receptor agonists inhibit Plasmodium falciparum by blocking a membrane channel.

Authors:  Christopher P Locher; Peter C Ruben; Jiri Gut; Philip J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

6.  Wright (a + b-) human erythrocytes and Plasmodium falciparum malaria.

Authors:  P Hermentin; P H David; L H Miller; M E Perkins; G Pasvol; W Dahr
Journal:  Blut       Date:  1985-02

7.  High-level artemisinin-resistance with quinine co-resistance emerges in P. falciparum malaria under in vivo artesunate pressure.

Authors:  Rajeev K Tyagi; Patrick J Gleeson; Ludovic Arnold; Rachida Tahar; Eric Prieur; Laurent Decosterd; Jean-Louis Pérignon; Piero Olliaro; Pierre Druilhe
Journal:  BMC Med       Date:  2018-10-01       Impact factor: 8.775
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.